Sechenov University began clinical trials of the COVID-19 vaccine produced by Russia’s Gamalei Institute of Epidemiology and Microbiology on June 18, 2020.

The first set of human clinical trials of the vaccine with eighteen volunteers in Russia was started on June 18.

The first set of human clinical trials of the vaccine with eighteen volunteers in Russia was started on June 18.The Russian Ministry of Health had sanctioned the human clinical trials on June 16, 2020, with Sechenov University selected as the site for the clinical study.

The Sechenov University at Moscow began the human clinical trials for the COVID-19 vaccine, named Gam-COVID-Vac Lyo, on June 18, 2020, which is produced by the Gamalei Institute of Epidemiology and Microbiology. The first group of volunteers included eighteen people; males and females, aged 18 to 65. The second group of 20 volunteers received the vaccine on June 23 at the Practical Research Centre for Interventional Cardiovasology.

The COVID-19 pandemic has given rise to a lot of potentially dangerous misinformation. For reliable advice on COVID-19 including symptoms, prevention and available treatment, please refer to the World Health Organisation or your national healthcare authority.